Login
Patents
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Auris Medical Reports New Data Highlighting Superior Bioavailability of AM-125 Compared to Oral BetahistineCompetitive IntelligenceFri, February 9th - 12:00 AM 2018
Newron Pharmaceuticals S.p.A. Announces Change in the Board of DirectorsCompetitive IntelligenceFri, February 9th - 12:00 AM 2018
Auris Medical Holding Ag Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Jan. 29, 2018)Competitive IntelligenceMon, February 12th - 12:00 AM 2018
Deals Shaping The Medical Industry, February 2018Competitive IntelligenceMon, February 12th - 12:00 AM 2018
Auris Medical Holding Ag Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Jan. 29, 2018)Competitive IntelligenceMon, February 12th - 12:00 AM 2018
Newron Pharmaceuticals to Present at the 20th Annual BIO CEO & Investor Conference in New YorkCompetitive IntelligenceMon, February 12th - 12:00 AM 2018
Managing Behavioral and Psychological Symptoms of DementiaCompetitive IntelligenceThu, March 1st - 12:00 AM 2018
Research report: Hippocampal GABAA antagonism reverses the novel object recognition deficit in sub-chronic phencyclidine-treated ratsCompetitive IntelligenceMon, April 16th - 12:00 AM 2018
IDOXURIDIN UND DESSEN ANALOGA ALS NEUROPROTEKTIVA ZUR BEHANDLUNG VON PARKINSONISMUSWIPO Parkinson's DiseaseWed, December 11th - 1:00 AM 2019
IQWiG: ‘Quality’ Registry Data Suitable for Benefit AssessmentsRegulatory Affairs Professional SocietyMon, January 27th - 5:07 PM 2020